[1] [2] Keep a log of injection sites to ensure systematic rotation
Pharmacokinetic analysis revealed it to be orally active with significantly increased metabolic stability, exhibiting a plasma half-life of 335.5 minutes, allowing for prolonged systemic availability [2]
In all cases, KL1 increased S
The Category 2 designation was not a finding that BPC-157 is dangerous per se, but rather that insufficient human safety data exists to justify its use in compounded medications without the oversight of the standard drug approval process
Concurrent medications influence dosing decisions
From experimental data of kinetic measurements of BRET, following vehicle and baseline corrections, quantification of induced responses from individual peptide concentrations was determined by calculating the net area under curve from the 10 min response (AUC 0-10min) ) in GraphPad Prism version 9.0.1 (GraphPad Software Inc., San Diego, CA)